ENPP1 and arterial calcification of infancy: Children suffering from generalized arterial calcification of infancy (GACI), caused by a mutation of the gene Enpp1, which is responsible for the conversion of ATP into AMP and PPi, could also benefit from PPi supplementation therapy.